Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × Time × Clear all

Status

Completed 3 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 312 Oxaliplatin 227 Capecitabine 227 Radiotherapy 209 Carboplatin 199 Docetaxel 196 Cyclophosphamide 191 Gemcitabine 189 apatinib 188 Paclitaxel 178 Drug Therapy 178 camrelizumab 166 Fluorouracil 165 Bevacizumab 165 Blood Specimen Collection 116 Irinotecan 109 sintilimab 108 Dexamethasone 105 Etoposide 103 toripalimab 99 Radiosurgery 97 Surgical Procedures, Operative 96 Pemetrexed 94 S 1 (combination) 93 pembrolizumab 91 anlotinib 88 Leucovorin 88 Surveys and Questionnaires 86 Rituximab 86 Nivolumab 86

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03764917 2020-03-24

NGS Combined With RNAseq on Tumor Immune Escape in NSCLC

Shanghai Pulmonary Hospital, Shanghai, China

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡